Logo image of ARTW

ART'S-WAY MANUFACTURING CO (ARTW) Stock Fundamental Analysis

NASDAQ:ARTW - Nasdaq - US0431681032 - Common Stock - Currency: USD

1.695  +0.04 (+2.11%)

Fundamental Rating

2

Overall ARTW gets a fundamental rating of 2 out of 10. We evaluated ARTW against 129 industry peers in the Machinery industry. ARTW has a bad profitability rating. Also its financial health evaluation is rather negative. ARTW is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ARTW had negative earnings in the past year.
In the past year ARTW had a positive cash flow from operations.
In multiple years ARTW reported negative net income over the last 5 years.
In multiple years ARTW reported negative operating cash flow during the last 5 years.
ARTW Yearly Net Income VS EBIT VS OCF VS FCFARTW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M

1.2 Ratios

Looking at the Return On Assets, with a value of -5.53%, ARTW is doing worse than 72.22% of the companies in the same industry.
ARTW has a Return On Equity of -11.52%. This is in the lower half of the industry: ARTW underperforms 73.81% of its industry peers.
Industry RankSector Rank
ROA -5.53%
ROE -11.52%
ROIC N/A
ROA(3y)0.84%
ROA(5y)-3.2%
ROE(3y)1.74%
ROE(5y)-5.6%
ROIC(3y)N/A
ROIC(5y)N/A
ARTW Yearly ROA, ROE, ROICARTW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10 -20

1.3 Margins

With a Gross Margin value of 27.40%, ARTW perfoms like the industry average, outperforming 41.27% of the companies in the same industry.
In the last couple of years the Gross Margin of ARTW has grown nicely.
ARTW does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y38.33%
GM growth 5Y9.77%
ARTW Yearly Profit, Operating, Gross MarginsARTW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

More info and screens

2

2. Health

2.1 Basic Checks

ARTW does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ARTW has been increased compared to 1 year ago.
ARTW has more shares outstanding than it did 5 years ago.
ARTW has a worse debt/assets ratio than last year.
ARTW Yearly Shares OutstandingARTW Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
ARTW Yearly Total Debt VS Total AssetsARTW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

An Altman-Z score of 2.32 indicates that ARTW is not a great score, but indicates only limited risk for bankruptcy at the moment.
ARTW has a Altman-Z score of 2.32. This is in the lower half of the industry: ARTW underperforms 61.90% of its industry peers.
ARTW has a debt to FCF ratio of 7.29. This is a slightly negative value and a sign of low solvency as ARTW would need 7.29 years to pay back of all of its debts.
With a Debt to FCF ratio value of 7.29, ARTW perfoms like the industry average, outperforming 47.62% of the companies in the same industry.
A Debt/Equity ratio of 0.62 indicates that ARTW is somewhat dependend on debt financing.
The Debt to Equity ratio of ARTW (0.62) is worse than 67.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 7.29
Altman-Z 2.32
ROIC/WACCN/A
WACC9.97%
ARTW Yearly LT Debt VS Equity VS FCFARTW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M

2.3 Liquidity

ARTW has a Current Ratio of 1.55. This is a normal value and indicates that ARTW is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.55, ARTW is doing worse than 75.40% of the companies in the same industry.
ARTW has a Quick Ratio of 1.55. This is a bad value and indicates that ARTW is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.37, ARTW is doing worse than 96.03% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 0.37
ARTW Yearly Current Assets VS Current LiabilitesARTW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for ARTW have decreased strongly by -252.49% in the last year.
Looking at the last year, ARTW shows a small growth in Revenue. The Revenue has grown by 0.34% in the last year.
Measured over the past years, ARTW shows a quite strong growth in Revenue. The Revenue has been growing by 8.95% on average per year.
EPS 1Y (TTM)-252.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.4%
Revenue 1Y (TTM)0.34%
Revenue growth 3Y10.55%
Revenue growth 5Y8.95%
Sales Q2Q%-27.64%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ARTW Yearly Revenue VS EstimatesARTW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
ARTW Yearly EPS VS EstimatesARTW Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

ARTW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ARTW Price Earnings VS Forward Price EarningsARTW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

65.87% of the companies in the same industry are cheaper than ARTW, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ARTW indicates a rather cheap valuation: ARTW is cheaper than 96.83% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.45
EV/EBITDA 22.87
ARTW Per share dataARTW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ARTW!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ART'S-WAY MANUFACTURING CO

NASDAQ:ARTW (2/5/2025, 8:00:00 PM)

1.695

+0.04 (+2.11%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)10-09 2024-10-09
Earnings (Next)02-11 2025-02-11
Inst Owners3.05%
Inst Owner Change0%
Ins Owners10.62%
Ins Owner Change4.47%
Market Cap8.53M
Analysts100
Price TargetN/A
Short Float %6.08%
Short Ratio0.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.28
P/FCF 8.45
P/OCF 4.5
P/B 0.76
P/tB 0.76
EV/EBITDA 22.87
EPS(TTM)-0.23
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.2
FCFY11.83%
OCF(TTM)0.38
OCFY22.22%
SpS6.14
BVpS2.24
TBVpS2.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.53%
ROE -11.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.4%
FCFM 3.26%
ROA(3y)0.84%
ROA(5y)-3.2%
ROE(3y)1.74%
ROE(5y)-5.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.47%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y38.33%
GM growth 5Y9.77%
F-Score4
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 7.29
Debt/EBITDA 13.53
Cap/Depr 102.02%
Cap/Sales 2.87%
Interest Coverage N/A
Cash Conversion 366.14%
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 0.37
Altman-Z 2.32
F-Score4
WACC9.97%
ROIC/WACCN/A
Cap/Depr(3y)140.76%
Cap/Depr(5y)110.29%
Cap/Sales(3y)3.81%
Cap/Sales(5y)3.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-252.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.4%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.34%
Revenue growth 3Y10.55%
Revenue growth 5Y8.95%
Sales Q2Q%-27.64%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-123.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y217.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y311.91%
OCF growth 3YN/A
OCF growth 5YN/A